Neutrophil gelatinase-associated lipocalin in diagnosis of kidney diseases


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Role of neutrophil gelatinase-associated lipocalin in diagnosis of acute kidney injury and chronis kidney disease is discussed.

Full Text

Restricted Access

References

  1. Davarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): A new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008; 241: 89—94.
  2. Kjeldsen L., Johnsen A.H., Senglöv H. et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993; 268: 10425-10432.
  3. Вельков В.В. NGAL — «ренальный тропонин»: ранний маркер острого повреждения почек. Научно-практический журнал «Клиниколабораторный консилиум» 2011; 2(38): 90—100.
  4. Schmidt-Ott K.M., Mori K., Li J.Y. et al. Dual Action of Neutrophil Gelatinase — Associated Lipocalin. J Am Soc Nephrol. 2007; 18: 407—413.
  5. Shrestha K., Borowski A.G., Troughton R.W. et al. Association between systemic Neutrophil Gelatinase-Associated Lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure. Congest Heart Fail. 2012; 18: 239—244.
  6. Matthaeus T., Schulze-Lohoff E., Ichimura T. et al. Co-regulation of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase-9 in the post ischemic rat kidney. Clin J Am Soc Nephrol. 2001; 12: 787A.
  7. Thrailkill K.M., Moreau C.S., Cockrell G.E. et al. Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus. Endocrine. 2010; 37(2): 336—343.
  8. Liangos O., Wald R., O’Bell J.W. et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: A national survey. Clin J Am Soc Nephrol. 2006; 1: 43—51.
  9. Wagener G., Jan M., Kim M. et al. Association between increases in urinary neutrophil gelatinase—associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006; 105: 485—491.
  10. De Mendonca A., Vincent J.L., Suter P.M. et al. Acute renal failure in the ICU: Risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000; 26: 915—921.
  11. Bennett M.R., Dent C.L. et al. Urinary NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin. J. Am. Soc. Nephrol. 2008; 3(3): 665—673.
  12. Koyner J.L., Bennett M.R., Worcester E.M. et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008; 74(8): 1059-1069.
  13. Волгина Г.В. Контраст-индуцированная нефропатия: патогенез, факторы риска, стратегия профилактики (Часть I). Нефрология и диализ 2006; 8(1): 69—77.
  14. Bachorzewska-Gajewska H., Malyszko J., Sitniewska E. et al. Could neutrophil gelatinase—associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values. Kidney Blood Press Res. 2007; 30: 408-415.
  15. Hirsch R., Dent C., Pfriem H. et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol. 2007; 22: 2089-2095.
  16. Wasilewska A., Zoch-Zwierz W., Taranta-Janusz K. et al. Neutrophil gelatinase—associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity. Pediatr Nephrol. 2010, 25: 889—897.
  17. Trachtman H., Christen E., Cnaan A. et al. Urinary neutrophil gelatinase— associated lipocalin in D+HUS: a novel marker of renal injury. Pediatr Nephrol. 2006; 21: 989—994.
  18. Yilmaz A., Sevketoglu E., Gedikbasi A. et al. Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Pediatr Nephrol. 2009; 24: 2387—2392.
  19. Bennet M. NGAL distinguishes steroid sensitivity in idiopathic nephritic syndrome. Pediatr Nephrol. 2012; 27: 807—812.
  20. Doaa M.Y., Amal S.E. Neutrophil gelatinase—associated lipocalin (NGAL) and kidney injury in children with focal segmental glomerulosclerosis. Iranian J Kidney Dis. 2012; 6: 355—360.
  21. Bolignano D., Lacquaniti A., Coppolino G. et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease. Clin J Am Soc Nephrol. 2009; 4: 337—344.
  22. Nishida M., Kawakatsu H., Okumura Y. et al. Serum and urinary NGAL levels in children with chronic renal diseases. Pediat Int. 2010; 52(4): 563—568.
  23. Damman K., van Veldhuisen D.J., Navis G. et al. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail. 2008; 10(10): 997—1000.
  24. Ding H., He Y., Li K. et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2007; 123: 227—234.
  25. Makris K., Markou N., Evodia E. et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med. 2009; 47(1): 79—82.
  26. Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т. Эпидемиологические исследования сердечной недостаточности: состояние вопроса. Cons medicum. 2002; 3: 112—114.
  27. Damman K., van Veldhuisen D.J., Navis G. et al. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail. 2008; 10(10): 997—1000.
  28. Choi K.M., Lee J.S., Kim E.J. et al. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol. 2008; 158(2): 203—207.
  29. Alvelos M., Pimentel R., Pinho E. et al. Neutrophil Gelatinase-Associated Lipocalin in the Diagnosis of Type 1 Cardio-Renal Syndrome in the General Ward. Clin J Am Soc Nephrol. 2011; 6: 476—481.
  30. Yndestad A., Landrø L., Ueland T. et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J. 2009; 30(10): 1229—1236.
  31. Шилов Е.М. Нефрология: Учебное пособие для послевузовского образования. М.: ГЭОТАР-Медиа 2007.
  32. Шестакова М.В. Современное понятие «хроническая болезнь почек»: методы диагностики, клиническое значение. Сахарный диабет. 2 008; 2: 4—7.
  33. Лебедева Н.О., Викулова О.К. Маркеры доклинической диагностики диабетической нефропатии у пациентов с сахарным диабетом 1 типа. Сахарный диабет. 2012; 2: 38—45.
  34. Yang Y.H., He X.J., Chen S.R. et al. Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study. Endocrine. 2009; 36(1): 45—51.
  35. Bolignano D., Lacquaniti A., Coppolino G. et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res. 2009; 32(2): 91—98.
  36. Nauta F.L., Boertien W.E., Bakker S.J. et al. Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes. Diabetes Care. 2011; 34: 975—981.
  37. Parikh C.R., Dahl N.K., Chapman A.B. et al. Evaluation of urine biomarkers of kidney injury in polycystic kidney disease. Kidney International. 2012; 81: 784—790.
  38. Bolignano D., Coppolino G., Campo S. et al. Neutrophil Gelatinase-Associated Lipocalin in Patients with Autosomal-Dominant Polycystic Kidney Disease. Am J Nephrol. 2007; 27: 373—378.
  39. Rubinstein T., Pitashny M., Levine B. et al. Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology. 2010; 49: 960—971.
  40. Suzuki M., Wiers K.M., Klein-Gitelman M.S. et al. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol. 2008; 23(3): 403—412.
  41. Fagundes C., Pépin M.-N., Guevara M. et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J Hepatol. 2012; 57(2): 267—273.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies